Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Arzneimittel-Forschung|September 1, 1991
[The hemodynamic effects of isradipine and nifedipine in hypertension]P Gross, K Koppenhagen, E Wudel, et al.Journal of Cardiovascular Pharmacology|January 1, 1992
Hemodynamic effects of isradipine and nifedipine in chronic sustained hypertensionP Gross, K Koppenhagen, E Wudel, et al.Journal of Cardiovascular Pharmacology|January 1, 1990
Isradipine: a new calcium antagonist with strong vasodilatory but negligible cardiodepressive effectsR Griebenow, W Kaufmann, L Krämer, et al.AJNR. American Journal of Neuroradiology|September 18, 2001
MR imaging and single-photon emission CT findings after gene therapy for human glioblastomaF W Floeth, A Aulich, K J Langen, et al.European Journal of Clinical Pharmacology|January 1, 1990
Renal effects of the new calcium channel blocking drug isradipineB K Krämer, M Häussler, K M Ress, et al.Arzneimittel-Forschung|March 1, 1994
[Vasoselective, substance-specific actions of isradipine on the great arteries of hypertensives in comparison to metoprolol]A Simon, I Merli, M Del Pino, et al.Anti-Cancer Drugs|March 1, 1997
Treatment of prolonged chemotherapy induced severe thrombocytopenia with recombinant human interleukin-3--a report on four casesL Färber, U Haus, G Füchsel, et al.Bone Marrow Transplantation|November 18, 1998
Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cellsS Hohaus, H Martin, B Wassmann, et al.Gene Therapy|December 8, 2000
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiformeN G Rainov, C M Kramm, U Banning, et al.European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II studyM Schuler, U Bruntsch, E Späth-Schwalbe, et al.Pageof 4